Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6007 clinical trials
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

In this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in participants that have prostate cancer and are scheduled for a radical prostatectomy.

neutrophil count
prostatectomy
carcinoma
  • 2 views
  • 05 Aug, 2020
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Eligibility Adults age 18 and older with pancreatic cancer, breast cancer, or a solid tumor that has not been cured by standard therapies. Also, children age 12-17 with a solid tumor (other than a muscle tumor) with no standard therapy options.

blood test
electrocardiogram
primary tumor
electroencephalogram
neutrophil count
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

graft versus host disease
chemotherapeutic agents
percutaneous endoscopic gastrostomy
interferon
refractory malignant glioma
  • 0 views
  • 16 Feb, 2024
  • 83 locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

neutrophil count
non-small cell carcinoma
stage ib lung cancer ajcc v8
non-small cell lung cancer
stage ia1 lung cancer ajcc v8
  • 0 views
  • 16 Feb, 2024
  • 22 locations
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

A study of CT-RD06 cell injection in patients with relapsed or refractory CD19+ B-cell hematological malignancy.

b-cell acute lymphoblastic leukemia
chemotherapy regimen
oximetry
lymphoblastic leukemia
ejection fraction
  • 0 views
  • 16 Feb, 2024
  • 1 location
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers RT-CAMSS Study

This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and side-effect management and coping skills, emotional support and validation, and proactive care via …

stage iiic colorectal cancer ajcc v8
irinotecan
gastrointestinal cancer
flot
carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Once they find this dose, they can test it in future participants to see if it is effective in treating their relapsed/refractory B-cell cell cancers. This study will also look at whether 19(T2)28z1xx CAR T cells work against participants' cancer.

monoclonal protein
tositumomab
pulse oximetry
chemoimmunotherapy
anti-cd20 monoclonal antibody
  • 0 views
  • 05 Aug, 2020
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

The primary objective of this study is to evaluate the safety and clinical activity of NKG2D-based CAR-T cells infusion in the treatment of relapsed/refractory NKG2DL+ solid tumors.

  • 0 views
  • 23 Nov, 2021
  • 1 location
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

investigational treatment
hematologic malignancy
allogeneic transplantation
cancer
  • 0 views
  • 16 Feb, 2024
  • 4 locations
Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer

Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue.

neutrophil count
squamous cell carcinoma of head and neck
absolute neutrophil count
recurrent squamous cell carcinoma
squamous cell carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location